Biogen
Scope
Date
~
-
Bio & Pharma
Samsung Bioepis seeks to buy Biogen biosimilar unit
Samsung Bioepis Co., a biopharmaceutical research and development unit under South Korea’s Samsung Group, seeks to buy a biosimilar business d...
Aug 02, 2023 (Gmt+09:00)
-
Mergers & Acquisitions
Samsung buys $2.3 bn Bioepis stake from Biogen to end partnership
Samsung Biologics Co. is acquiring a nearly 50% stake in a biosimilar joint venture with Biogen Inc. from the US biotechnology company for $2.3 bill...
Jan 28, 2022 (Gmt+09:00)
language -
M&As
Samsung Group in negotiations to buy Biogen
South Korea's Samsung Group is in negotiations to buy Biogen Inc., a leading US-based drugmaker for neurological conditions such as Alzheimer's and ...
Dec 30, 2021 (Gmt+09:00)